Pharmacogenomics · 2016 · 23 citations · 17 references
MedicineGeneticsPharmacologyPharmacogeneticsPharmacogenomicsRheumatologyAutoimmune Disease Susceptibility GenesAutoimmune DiseasesDisease Susceptibility LociGenetic Susceptibility To AutoimmunityGenotype-phenotype Association AnalysisRheumatoid ArthritisAutoimmune Disease GeneticsDisease-specific Risk AllelesGenotype InterpretationGenotype-based Drug Response PredictionTreatment Response Biomarkers
AIM: To find the association of ATIC 347C>G gene polymorphism with methotrexate (MTX) treatment response and MTX-induced adverse events in south Indian Tamil patients with rheumatoid arthritis. PATIENTS & METHODS: A total of 319 rheumatoid arthritis and 310 healthy controls were recruited for the study and ATIC 347C>G gene polymorphism was analyzed by PCR-RFLP method. RESULTS: The genotype and allele frequencies of ATIC 347 C>G SNP did not differ between good and nonresponders and hence this SNP was not found to be associated with MTX treatment response. However, the ATIC 347 GG genotype (p = 0.02; odds ratio [OR]: 4.46; 95% CI: 1.28-15.52) and mutant G allele was associated with MTX-induced gastrointestinal adverse events (p = 0.01; OR: 2.60; 95% CI: 1.27-5.35). CONCLUSION: ATIC 347C>G gene polymorphism may be associated with the development of MTX induced gastrointestinal adverse events.
17
Daniel Aletaha, Tuhina Neogi, Alan J. Silman et al. · Arthritis & Rheumatism · 2010 · 9.6K citations · Full text
Medicine, Internal Medicine, Clinical Classification Systems +13
Anke M. van Gestel, M.L.L. Prevoo, Martin A. van't Hof et al. · Arthritis & Rheumatism · 1996 · 1.6K citations
Methotrexate in Rheumatoid Arthritis
Jerzy Świerkot, Jacek Szechiński · Annals of Internal Medicine · 1987 · 348 citations
Thierry Dervieux, Daniel E. Furst, Diana Orentas Lein et al. · Arthritis & Rheumatism · 2004 · 334 citations